All Articles

A Pennsylvania clinic's radical 19-day protocol, powered by advanced hyperbaric tech, is showing remarkable results for veterans with TBI and PTSD.

A new fintech, 1TCH, has launched a single platform for payments, projects, and invoicing. Is this ambitious all-in-one the future for freelancers?

By ceding a $5.8B legacy block, Lincoln is doubling down on its strategy to enhance cash flow and fortify its balance sheet for long-term resilience.

Etsy's divestiture of Depop to eBay is more than a sale; it's a strategic reset. We explore the why behind this billion-dollar e-commerce shake-up.

A favorable valuation for pre-revenue HG Home Guardian validates its vision for proactive home care, signaling a major shift from reactive fixes to predictive intelligence.

Clinical research leader Novotech offers a strategic roadmap for biotech and pharma, aiming to de-risk and accelerate the complex world of autoimmune drug development.

Federal Signal's record quarter isn't just a win for Wall Street. It's a sign of surging investment in the essential tools that keep our cities clean and safe.

eBay's acquisition of Depop isn't just about clothes; it's a high-stakes play for relevance, a bid to capture the circular economy, and a test of survival.

With a new CEO known for navigating tough markets and a strategic move to Houston, Alléo Energy is shifting from R&D to commercial execution.

As AI floods cybersecurity, Invicti's new Agentic Pentest bets on a hybrid approach, blending AI reasoning with proven tech to find flaws others miss.

As rising temperatures amplify India's public health risks, a new campaign tackles a persistent 'know-do gap' in dehydration treatment. But is consumer education enough?

South Korean robotic hand specialist Tesollo targets a post-2027 IPO, fueled by strategic Series B funding and a mission to dominate industrial automation.

A startup is using real neurons to discover software that slashes AI costs. We analyze the tech, the market, and the profound implications of this new frontier.

Nscale's acquisition of Anyscale for a reported $1.65B creates a full-stack AI powerhouse, challenging cloud giants with a vertically integrated platform.

Altria touts shareholder returns and narrows profit guidance, but a deeper look reveals weakening Marlboro sales and a high-stakes, uncertain pivot to smoke-free.

UNCF's Project ACCLAIM gives HBCU students $4M investment funds to manage, forging a new pipeline of financial leaders and a model for institutional self-reliance.

By assembling a 'dream team' of scientific advisors, INmune Bio isn't just advancing a drug; it's fortifying the very structure of cell therapy development.

With myopia rates soaring, HOYA's MiYOSMART iQ lens enters Canada with unprecedented clinical results, signaling a major strategic shift in pediatric vision care.

SunCoke Energy's stellar Q2 results reveal a masterstroke in strategy, with its Phoenix acquisition driving record growth and diversifying the firm's future.

With a lens clinically shown to stop nearsightedness in 9 of 10 kids, HOYA isn't just launching a product; it's making a power play in a blurry market.